The Inhibition of Angiogenesis by Shenmai Combined with Hydroxycamptothecin

QIAN Xiao-ping,LIU Bao-rui,HU Jing,HU Wen-jing,ZOU Xi

DOI: https://doi.org/10.3969/j.issn.1007-3639.2006.11.018

2006-01-01

Abstract:Background and purpose:It has been reported that some low dose traditional Chinese medicine along with low dose chemotherapy drugs could selectively inhibit the function of vascular endothelial cell. This experiment aims to study the impact of Shenmai combined with hydroxycamptothecin on angiogenesis in vitro and vivo. Methods:HepG Ⅱ cells was used as control group, proliferations of human microvascular endothelial cell(HMVEC) were measured by MTT colorimetric assay. After treated by Shenmai combined with hydroxycamptothecine. Migration of HMVEC was observed by a microcarrier-based three-dimensional angiogenesis model in vitro. We also studied the impact of the combination on angiogenesis in chick embryo choriallantoic membrane (CAM) model.Results:Shenmai injection (40μl/ml) and hydroxycamptothecine (20ng/ml) can inhibit the prolifetation of HMVEC; the rate of inhibition were 18% for Shenmai alone、31.7% for hydroxycamptothecine alone and 43.6% for the combination, respectively, they could also inhibit the prolifetation of HepG Ⅱ cell; the rate of inhibition were 1.2%、0.9% and 19.4%, respectively; there were synergistic effect exist if Shenmai injection (40μl/ml) used with hydroxycamptothecine (20ng/ml) in HMVEC; the above concentration of Shenmai and hydroxycamptothecine could also inhibit the sprouts of HMVEC, they had synergistically interacted with each other and the effect was correlated with incubation time (the coefficient was 0.988, P= 0.007); the same response could be observed in CAM model in terms of angiogenesis, the rate of inhibition were 30%for Shenmai alone、40%for hydroxycamptothecine alone and 60% for the combination, respectively.Conclusions:Low dose Shenmai injection (40μl/ml)、hydroxycamptothecine (20ng/ml) can inhibit angiogenesis both in vitro and vivo, but had no effects to HepG Ⅱ cell, it seems to be cell lineage dependent; ②Low dose Shenmai injection (40μl/ml) combined with hydroxycamptothecine (20ng/ml) can synergistically inhabit the migration of HMVEC in vitro and angiogenesis in vivo.